IMA is loading

Main Financial Data 2020

Main Data: 30/06 Year 2020
Consolidated income statement (international practice in accordance with IAS/IFRS) Millions / Euro
– total revenues 636.4
– industrial gross profit 223.6
– total operating cost 193.7
– operating profit 29.9
– net financial expense 12.3
– profit attributable to equity holders of the parent 16.5

 

Consolidated balance sheet Millions / Euro
– working capital  147.6
– non-current assets 1,225.4
– provision for severance indemnities and other provisions -196.8
– net debt -665.3
– equity pertaining to the group and minority interests 513.6

 

Other information Millions / Euro
– depreciation, amortization and impairment 47.1
– R & D costs 30.2

 

  No.
Employees 6,200

 

  Euro
Share capital 22,470,504.68

 

 

 

 

Dismissclose

IMA Pharma
@ Achema

Explore the dedicated website and get a free entry pass with IMA